Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Testicular Neoplasms 7Retinoblastoma 5Ovarian Neoplasms 5Testicular Germ Cell Tumor 4Sarcoma 4Central Nervous System Neoplasms 4Wilms Tumor 3Teratoma 3Ovarian Germ Cell Cancer 3Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Medulloblastoma 3Liver Neoplasms 3Kidney Neoplasms 3Hepatoblastoma 3Dendritic Cell Sarcoma, Interdigitating 3Burkitt Lymphoma 3Waldenstrom Macroglobulinemia 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Neoplasms, Plasma Cell 2Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2

Interventions

Cisplatin 11Paclitaxel 9Ifosfamide 9Filgrastim 8Etoposide 8Bleomycin 7Carboplatin 5pegfilgrastim 3Peripheral Blood Stem Cell Transplantation 3liposomal amphotericin B 2Therapeutics 2Radiotherapy 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2sargramostim 1sabarubicin 1ixabepilone 1etoposide phosphate 1aldesleukin 1Vincristine 1Vinblastine 1Thiotepa 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Ribavirin 1Psychiatric Rehabilitation 1Palivizumab 1Oxaliplatin 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endodermal Sinus Tumor × Thiotepa × Genitourinary × Clear all
NCT00432094 2022-05-17

Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
23 enrolled 11 charts
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡